MoneyWorks4Me

Astrazeneca Pharma I - Quaterly Results

27 May 2024 Evaluate
The sales for the March 2024 quarter moved up 34.60% to Rs. 3831.99 millions as compared to Rs. 2847.04 millions during the corresponding quarter last year.The Net Profit of the company reported a remarkable increase of 128.58% to Rs. 394.78  millions  from Rs. 172.71 millions in previous same quarter.Operating profit for the quarter ended March 2024 decreased to 581.18 millions as compared to 678.46 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 3831.99 2847.04 34.60 12955.28 10029.71 29.17 12955.28 10029.71 29.17
Other Income 87.30 79.97 9.17 348.00 261.02 33.32 348.00 261.02 33.32
PBIDT 581.18 678.46 -14.34 2192.52 1912.27 14.66 2192.52 1912.27 14.66
Interest 0.00 0.88 0.00 12.01 6.33 89.73 12.01 6.33 89.73
PBDT 581.18 275.29 111.12 2344.77 1503.65 55.94 2344.77 1503.65 55.94
Depreciation 37.64 42.49 -11.41 149.40 162.60 -8.12 149.40 162.60 -8.12
PBT 543.54 232.80 133.48 2195.37 1341.05 63.71 2195.37 1341.05 63.71
TAX 148.76 60.09 147.56 580.28 348.12 66.69 580.28 348.12 66.69
Deferred Tax -6.39 -23.73 -73.07 -9.03 -34.90 -74.13 -9.03 -34.90 -74.13
PAT 394.78 172.71 128.58 1615.09 992.93 62.66 1615.09 992.93 62.66
Equity 50.00 50.00 0.00 50.00 50.00 0.00 50.00 50.00 0.00
PBIDTM(%) 15.17 23.83 -36.36 16.92 19.07 -11.24 16.92 19.07 -11.24
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..